Revelation Biosciences In...
(REVB)
undefined
undefined%
At close: undefined
0.37
3.06%
After-hours Dec 13, 2024, 07:21 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Revenue | - | - | - | - | - |
Cost of Revenue | 25.05K | 40.01K | 69.17K | - | - |
Gross Profit | -25.05K | -40.01K | -69.17K | - | - |
Operating Income | -8.66M | -10.86M | -11.95M | -145.49K | -3.64K |
Interest Income | - | - | - | 10.91K | - |
Pretax Income | -120.25K | -10.83M | -11.99M | -1.63M | -3.64K |
Net Income | -120.25K | -10.79M | -11.99M | -1.63M | -3.64K |
Selling & General & Admin | 4.51M | 5.49M | 5.04M | 145.49K | 3.64K |
Research & Development | 4.15M | 5.38M | 6.91M | 2.56M | - |
Other Expenses | - | 34.96K | -36.35K | - | - |
Operating Expenses | 8.66M | 10.86M | 11.95M | 145.49K | 3.64K |
Interest Expense | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | 144.26K | - |
Cost & Expenses | 8.66M | 10.86M | 11.95M | 145.49K | 3.64K |
Income Tax | - | -34.96K | -219.78K | -3.80K | -171.86K |
Shares Outstanding (Basic) | 228.00K | 17.97K | 9.40K | 8.66K | 8.66K |
Shares Outstanding (Diluted) | 228.64K | 17.97K | 9.40K | 8.66K | 8.66K |
EPS (Basic) | -0.53 | -600.77 | -1.28K | -188.18 | -0.42 |
EPS (Diluted) | -0.53 | -600.77 | -1.28K | -188.18 | -0.42 |
EBITDA | -95.21K | -10.84M | -11.93M | -145.49K | -3.64K |
Depreciation & Amortization | 25.05K | 40.01K | 69.17K | 3.80M | 171.86K |